Table 3. Biochemical results.
Parameter | Control (n = 18) | HTDD− (n = 38) | HTDD+ (n = 56) |
PC, µmol/g | 0.191 ± 0.131 | 0.306 ± 0.214* | 0.29 ± 0.246* |
Plasma BH4, nmol/mL | 0.917 ± 0.351 | 1.98 ± 2.1** | 2.04 ± 1.99** |
Total biopterin, nmol/mL | 2.01 ± 0.86 | 3.05 ± 2.8 | 2.98 ± 2.46* |
CRP, mg/L | 1.97 ± 1.67 | 2.91 ± 2.63 | 4.17 ± 4.21** |
IL-6, pg/mL | 1.88 ± 1.04 | 2.4 ± 2.91 | 3.0 ± 4.49 |
TNF-α, pg/mL | 0.854 ± 0.778 | 1.75 ± 2.19* | 2.26 ± 4.62* |
FIB, g/L | 4.03 ± 0.61 | 4.46 ± 0.93 | 4.56 ± 0.95 |
PAI-I, ng/mL | 11.62 ± 5.44 | 21.11 ± 11.21** | 21.23 ± 16.16** |
VWF, Ag% | 168.03 ± 57.59 | 148.27 ± 39.15 | 156.58 ± 48.93 |
cGA, ng/mL | 75.85 ± 17.3 | 136.04 ± 162.71 | 148.16 ± 166.34** |
BNP, pg/mL | 15.89 ± 9.24 | 29.8 ± 32.3* | 43.49 ± 69.41** |
*P < 0.05, **P < 0.01 vs. the control group. BH4: tetrahydrobiopterin; BNP: B-type natriuretic peptide; cGA: chromogranin A; CRP: C-reactive protein; FIB: fibrinogen; IL-6: interleukin-6; PAI-I: plasminogen activator inhibitor type I; PC: protein carbonylation; TNF-α: tumor necrosis factor-α; VWF: von Willebrand factor.